144 related articles for article (PubMed ID: 21081126)
21. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
22. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells.
Gnanasekar M; Thirugnanam S; Zheng G; Chen A; Ramaswamy K
Int J Oncol; 2009 May; 34(5):1241-6. PubMed ID: 19360337
[TBL] [Abstract][Full Text] [Related]
23. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A.
Cans C; Passer BJ; Shalak V; Nancy-Portebois V; Crible V; Amzallag N; Allanic D; Tufino R; Argentini M; Moras D; Fiucci G; Goud B; Mirande M; Amson R; Telerman A
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13892-7. PubMed ID: 14623968
[TBL] [Abstract][Full Text] [Related]
24. Transduction of translationally controlled tumor protein employing TCTP-derived protein transduction domain.
Maeng J; Kim HY; Shin DH; Lee K
Anal Biochem; 2013 Apr; 435(1):47-53. PubMed ID: 23256924
[TBL] [Abstract][Full Text] [Related]
25. TCTP protects from apoptotic cell death by antagonizing bax function.
Susini L; Besse S; Duflaut D; Lespagnol A; Beekman C; Fiucci G; Atkinson AR; Busso D; Poussin P; Marine JC; Martinou JC; Cavarelli J; Moras D; Amson R; Telerman A
Cell Death Differ; 2008 Aug; 15(8):1211-20. PubMed ID: 18274553
[TBL] [Abstract][Full Text] [Related]
26. Lessons from tumor reversion for cancer treatment.
Amson R; Karp JE; Telerman A
Curr Opin Oncol; 2013 Jan; 25(1):59-65. PubMed ID: 23165143
[TBL] [Abstract][Full Text] [Related]
27. Cellular uptake mechanism of TCTP-PTD in human lung carcinoma cells.
Kim HY; Kim S; Pyun HJ; Maeng J; Lee K
Mol Pharm; 2015 Jan; 12(1):194-203. PubMed ID: 25423047
[TBL] [Abstract][Full Text] [Related]
28. Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.
Kloc M; Tejpal N; Sidhu J; Ganachari M; Flores-Villanueva P; Jennings NB; Sood AK; Kubiak JZ; Ghobrial RM
Folia Histochem Cytobiol; 2012 Oct; 50(3):358-67. PubMed ID: 23042265
[TBL] [Abstract][Full Text] [Related]
29. Suppressor of Variegation 3-9 Homolog 2, a Novel Binding Protein of Translationally Controlled Tumor Protein, Regulates Cancer Cell Proliferation.
Kim AR; Sung JY; Rho SB; Kim YN; Yoon K
Biomol Ther (Seoul); 2019 Mar; 27(2):231-239. PubMed ID: 30763986
[TBL] [Abstract][Full Text] [Related]
30. Interaction of OKL38 and p53 in regulating mitochondrial structure and function.
Hu J; Yao H; Gan F; Tokarski A; Wang Y
PLoS One; 2012; 7(8):e43362. PubMed ID: 22912861
[TBL] [Abstract][Full Text] [Related]
31. TCTP as therapeutic target in cancers.
Acunzo J; Baylot V; So A; Rocchi P
Cancer Treat Rev; 2014 Jul; 40(6):760-9. PubMed ID: 24650927
[TBL] [Abstract][Full Text] [Related]
32. TCTP as a therapeutic target in melanoma treatment.
Boia-Ferreira M; BasÃlio AB; Hamasaki AE; Matsubara FH; Appel MH; Da Costa CRV; Amson R; Telerman A; Chaim OM; Veiga SS; Senff-Ribeiro A
Br J Cancer; 2017 Aug; 117(5):656-665. PubMed ID: 28751755
[TBL] [Abstract][Full Text] [Related]
33. Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22.
Lee JH; Rho SB; Park SY; Chun T
FEBS Lett; 2008 Apr; 582(8):1210-8. PubMed ID: 18325344
[TBL] [Abstract][Full Text] [Related]
34. PNAS-4 expression and its relationship to p53 in colorectal cancer.
Zhou B; Yan H; Li Y; Wang R; Chen K; Zhou Z; Sun X
Mol Biol Rep; 2012 Jan; 39(1):243-9. PubMed ID: 21556770
[TBL] [Abstract][Full Text] [Related]
35. Identification of the self-interaction of rat TCTP/IgE-dependent histamine-releasing factor using yeast two-hybrid system.
Yoon T; Jung J; Kim M; Lee KM; Choi EC; Lee K
Arch Biochem Biophys; 2000 Dec; 384(2):379-82. PubMed ID: 11368327
[TBL] [Abstract][Full Text] [Related]
36. TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function.
Bereczki O; Ujfaludi Z; Pardi N; Nagy Z; Tora L; Boros IM; Balint E
BMC Mol Biol; 2008 Jun; 9():57. PubMed ID: 18549481
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of translationally controlled tumor protein (TCTP) can lead to radioactive susceptibility and chemosensitivity in lung cancer cells.
Du J; Yang P; Kong F; Liu H
Oncotarget; 2017 Nov; 8(60):101922-101935. PubMed ID: 29254214
[TBL] [Abstract][Full Text] [Related]
38. Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis.
Yuan L; Tian C; Wang H; Song S; Li D; Xing G; Yin Y; He F; Zhang L
EMBO Rep; 2012 Apr; 13(4):363-70. PubMed ID: 22334068
[TBL] [Abstract][Full Text] [Related]
39. Current Understanding of the TCTP Interactome.
Li S; Ge F
Results Probl Cell Differ; 2017; 64():127-136. PubMed ID: 29149405
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target.
Rozan LM; El-Deiry WS
Cancer Biol Ther; 2006 Sep; 5(9):1228-35. PubMed ID: 16969126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
